Verastem Historical Financial Ratios
| VSTM Stock | USD 4.00 0.07 1.78% |
Verastem is promptly reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 35.54, Dividend Yield of 0.0, PTB Ratio of 3.29 or Days Sales Outstanding of 3.73 will help investors to properly organize and evaluate Verastem financial condition quickly.
Verastem |
About Verastem Financial Ratios Analysis
VerastemFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Verastem investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Verastem financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Verastem history.
Verastem Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Verastem stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Verastem sales, a figure that is much harder to manipulate than other Verastem multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Verastem's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Verastem current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.At this time, Verastem's Current Ratio is very stable compared to the past year. As of the 24th of November 2024, Receivables Turnover is likely to grow to 121.51, while Book Value Per Share is likely to drop 3.38.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 27.5 | 17.39 | 15.23 | 14.47 | Receivables Turnover | 3.98 | 83.74 | 96.3 | 121.51 |
Verastem fundamentals Correlations
Click cells to compare fundamentals
Verastem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Verastem fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 5.72 | 3.69 | 174.15 | 29.84 | 26.85 | 35.54 | |
| Ptb Ratio | 13.93 | 2.83 | 4.08 | 1.63 | 3.13 | 3.29 | |
| Days Sales Outstanding | 52.78 | 0.99 | 91.74 | 4.36 | 3.92 | 3.73 | |
| Book Value Per Share | 1.15 | 9.02 | 6.02 | 2.94 | 3.56 | 3.38 | |
| Operating Cash Flow Per Share | (22.29) | (2.62) | (3.68) | (3.95) | (3.92) | (4.12) | |
| Stock Based Compensation To Revenue | 0.49 | 0.0917 | 3.76 | 2.33 | 2.1 | 1.1 | |
| Capex To Depreciation | 0.003212 | 0.0263 | 2.72 | (0.0619) | (0.0712) | (0.0677) | |
| Pb Ratio | 13.93 | 2.83 | 4.08 | 1.63 | 3.13 | 3.29 | |
| Ev To Sales | 9.39 | 3.18 | 126.42 | 11.4 | 10.26 | 9.75 | |
| Free Cash Flow Per Share | (22.29) | (2.62) | (3.69) | (3.95) | (3.92) | (4.12) | |
| Roic | (0.54) | (1.35) | (0.37) | (0.79) | (1.01) | (0.98) | |
| Net Income Per Share | (27.22) | (5.3) | (5.58) | (4.58) | (3.96) | (4.16) | |
| Payables Turnover | 0.29 | 18.0 | 0.0895 | 0.0241 | 0.00863 | 0.008199 | |
| Research And Ddevelopement To Revenue | 2.62 | 0.47 | 19.17 | 19.48 | 17.53 | 18.4 | |
| Cash Per Share | 12.15 | 11.05 | 12.33 | 5.45 | 6.26 | 5.95 | |
| Pocfratio | (0.72) | (9.75) | (6.68) | (1.22) | (2.08) | (2.18) | |
| Interest Coverage | (6.42) | (3.13) | (6.16) | (34.13) | (22.25) | (23.36) | |
| Capex To Operating Cash Flow | (5.1E-5) | (9.85E-4) | (0.003663) | (8.1E-5) | (7.3E-5) | (7.7E-5) | |
| Pfcf Ratio | (0.72) | (9.74) | (6.66) | (1.22) | (2.08) | (2.18) | |
| Days Payables Outstanding | 1.3K | 20.28 | 4.1K | 15.2K | 42.3K | 44.4K | |
| Income Quality | 0.93 | 0.49 | 0.75 | 0.86 | 0.99 | 0.63 | |
| Roe | (23.58) | (0.59) | (0.93) | (1.56) | (1.52) | (1.6) | |
| Ev To Operating Cash Flow | (1.18) | (8.4) | (4.85) | (0.46) | (1.65) | (1.73) | |
| Pe Ratio | (0.59) | (4.82) | (4.41) | (1.05) | (2.05) | (2.16) | |
| Ev To Free Cash Flow | (1.18) | (8.39) | (4.83) | (0.46) | (1.65) | (1.73) | |
| Earnings Yield | (0.31) | (1.69) | (0.21) | (0.95) | (0.49) | (0.51) | |
| Current Ratio | 2.84 | 8.48 | 5.69 | 4.29 | 5.45 | 10.12 | |
| Tangible Book Value Per Share | (2.07) | 9.02 | 6.02 | 2.94 | 3.56 | 3.38 | |
| Receivables Turnover | 6.92 | 370.36 | 3.98 | 83.74 | 96.3 | 121.51 | |
| Graham Number | 26.59 | 32.8 | 27.5 | 17.39 | 15.23 | 14.47 | |
| Shareholders Equity Per Share | 1.15 | 9.02 | 6.02 | 2.94 | 2.6 | 2.47 | |
| Debt To Equity | 14.5 | 0.17 | 0.0105 | 0.52 | 0.72 | 0.68 | |
| Capex Per Share | 0.001126 | 0.002583 | 0.0135 | 3.17E-4 | 3.65E-4 | 3.47E-4 | |
| Graham Net Net | (9.48) | 8.01 | 7.44 | 2.49 | 3.03 | 2.88 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share 0.331 | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (1.37) |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.